Emergence of colistin resistance in Enterobacter aerogenes from Croatia

Branka Bedenić, Mirna Vranić-Ladavac, Carolina Venditti, Arjana Tambić-Andrašević, Nada Barišić, Marija Gužvinec, Natalie Karčić, Nicola Petrosillo, Ranko Ladavac, Antonino di Caro

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A colistin-resistant Enterobacter aerogenes [study code 12264] was isolated from the tracheal aspirate of a 71-year-old male patient in the General Hospital [GH] in Pula, Croatia. The patient was previously treated in University Hospital Centre in Rijeka with colistin in order to eradicate Acinetobacter baumannii isolate, susceptible only to colistin and tigecycline. Genes encoding ESBLs [blaTEM, blaSHV, blaCTX-M, blaPER-1] were screened by PCR. The strain was shown to possess blaCTX-M-15 and blaTEM-1 genes. To asses genes possibly involved in resistance to colistin the chromosomal enconding mgrB gene and the plasmid-mediated mcr-1 and mcr-2 genes were screened as described previously. Mcr-1 and mcr-2 genes were not detected and mgrB gene presented a wild-type sequence. PCR-based Replicon typing method [PBRT] conducted on an E. aerogenes isolate, showed that the strain carried an IncN plasmid. Adaptive mechanisms such as changes of the bacterial cell outer membrane that cause porin decrease or presence of an efflux pump, due to selection pressure exerted by the therapeutic administration of colistin, could be responsible for the development of colistin resistance in our strain, as recently reported in E. aerogenes from France. Due to effective infection control measures, the colistin-resistant strain did not spread to other patients or hospital wards. This is the first report of an ESBL-producing, colistin-resistant E. aerogenes in clinically relevant samples such as endotracheal aspirate and blood culture, showing the presence of this rare resistance profile among Gram-negative bacteria.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalJournal of Chemotherapy
DOIs
Publication statusAccepted/In press - Oct 24 2017

Fingerprint

Enterobacter aerogenes
Colistin
Croatia
Genes
Plasmids
Acinetobacter baumannii
Polymerase Chain Reaction
Porins
Replicon
Equidae
Infection Control
Gram-Negative Bacteria
General Hospitals
France
Cell Membrane
Pressure

Keywords

  • Colistin
  • Enterobacter aerogenes
  • Resistance

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Bedenić, B., Vranić-Ladavac, M., Venditti, C., Tambić-Andrašević, A., Barišić, N., Gužvinec, M., ... di Caro, A. (Accepted/In press). Emergence of colistin resistance in Enterobacter aerogenes from Croatia. Journal of Chemotherapy, 1-4. https://doi.org/10.1080/1120009X.2017.1382121

Emergence of colistin resistance in Enterobacter aerogenes from Croatia. / Bedenić, Branka; Vranić-Ladavac, Mirna; Venditti, Carolina; Tambić-Andrašević, Arjana; Barišić, Nada; Gužvinec, Marija; Karčić, Natalie; Petrosillo, Nicola; Ladavac, Ranko; di Caro, Antonino.

In: Journal of Chemotherapy, 24.10.2017, p. 1-4.

Research output: Contribution to journalArticle

Bedenić, B, Vranić-Ladavac, M, Venditti, C, Tambić-Andrašević, A, Barišić, N, Gužvinec, M, Karčić, N, Petrosillo, N, Ladavac, R & di Caro, A 2017, 'Emergence of colistin resistance in Enterobacter aerogenes from Croatia', Journal of Chemotherapy, pp. 1-4. https://doi.org/10.1080/1120009X.2017.1382121
Bedenić B, Vranić-Ladavac M, Venditti C, Tambić-Andrašević A, Barišić N, Gužvinec M et al. Emergence of colistin resistance in Enterobacter aerogenes from Croatia. Journal of Chemotherapy. 2017 Oct 24;1-4. https://doi.org/10.1080/1120009X.2017.1382121
Bedenić, Branka ; Vranić-Ladavac, Mirna ; Venditti, Carolina ; Tambić-Andrašević, Arjana ; Barišić, Nada ; Gužvinec, Marija ; Karčić, Natalie ; Petrosillo, Nicola ; Ladavac, Ranko ; di Caro, Antonino. / Emergence of colistin resistance in Enterobacter aerogenes from Croatia. In: Journal of Chemotherapy. 2017 ; pp. 1-4.
@article{ade70450f32d4e9a9a4861126e854a94,
title = "Emergence of colistin resistance in Enterobacter aerogenes from Croatia",
abstract = "A colistin-resistant Enterobacter aerogenes [study code 12264] was isolated from the tracheal aspirate of a 71-year-old male patient in the General Hospital [GH] in Pula, Croatia. The patient was previously treated in University Hospital Centre in Rijeka with colistin in order to eradicate Acinetobacter baumannii isolate, susceptible only to colistin and tigecycline. Genes encoding ESBLs [blaTEM, blaSHV, blaCTX-M, blaPER-1] were screened by PCR. The strain was shown to possess blaCTX-M-15 and blaTEM-1 genes. To asses genes possibly involved in resistance to colistin the chromosomal enconding mgrB gene and the plasmid-mediated mcr-1 and mcr-2 genes were screened as described previously. Mcr-1 and mcr-2 genes were not detected and mgrB gene presented a wild-type sequence. PCR-based Replicon typing method [PBRT] conducted on an E. aerogenes isolate, showed that the strain carried an IncN plasmid. Adaptive mechanisms such as changes of the bacterial cell outer membrane that cause porin decrease or presence of an efflux pump, due to selection pressure exerted by the therapeutic administration of colistin, could be responsible for the development of colistin resistance in our strain, as recently reported in E. aerogenes from France. Due to effective infection control measures, the colistin-resistant strain did not spread to other patients or hospital wards. This is the first report of an ESBL-producing, colistin-resistant E. aerogenes in clinically relevant samples such as endotracheal aspirate and blood culture, showing the presence of this rare resistance profile among Gram-negative bacteria.",
keywords = "Colistin, Enterobacter aerogenes, Resistance",
author = "Branka Bedenić and Mirna Vranić-Ladavac and Carolina Venditti and Arjana Tambić-Andrašević and Nada Barišić and Marija Gužvinec and Natalie Karčić and Nicola Petrosillo and Ranko Ladavac and {di Caro}, Antonino",
year = "2017",
month = "10",
day = "24",
doi = "10.1080/1120009X.2017.1382121",
language = "English",
pages = "1--4",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",

}

TY - JOUR

T1 - Emergence of colistin resistance in Enterobacter aerogenes from Croatia

AU - Bedenić, Branka

AU - Vranić-Ladavac, Mirna

AU - Venditti, Carolina

AU - Tambić-Andrašević, Arjana

AU - Barišić, Nada

AU - Gužvinec, Marija

AU - Karčić, Natalie

AU - Petrosillo, Nicola

AU - Ladavac, Ranko

AU - di Caro, Antonino

PY - 2017/10/24

Y1 - 2017/10/24

N2 - A colistin-resistant Enterobacter aerogenes [study code 12264] was isolated from the tracheal aspirate of a 71-year-old male patient in the General Hospital [GH] in Pula, Croatia. The patient was previously treated in University Hospital Centre in Rijeka with colistin in order to eradicate Acinetobacter baumannii isolate, susceptible only to colistin and tigecycline. Genes encoding ESBLs [blaTEM, blaSHV, blaCTX-M, blaPER-1] were screened by PCR. The strain was shown to possess blaCTX-M-15 and blaTEM-1 genes. To asses genes possibly involved in resistance to colistin the chromosomal enconding mgrB gene and the plasmid-mediated mcr-1 and mcr-2 genes were screened as described previously. Mcr-1 and mcr-2 genes were not detected and mgrB gene presented a wild-type sequence. PCR-based Replicon typing method [PBRT] conducted on an E. aerogenes isolate, showed that the strain carried an IncN plasmid. Adaptive mechanisms such as changes of the bacterial cell outer membrane that cause porin decrease or presence of an efflux pump, due to selection pressure exerted by the therapeutic administration of colistin, could be responsible for the development of colistin resistance in our strain, as recently reported in E. aerogenes from France. Due to effective infection control measures, the colistin-resistant strain did not spread to other patients or hospital wards. This is the first report of an ESBL-producing, colistin-resistant E. aerogenes in clinically relevant samples such as endotracheal aspirate and blood culture, showing the presence of this rare resistance profile among Gram-negative bacteria.

AB - A colistin-resistant Enterobacter aerogenes [study code 12264] was isolated from the tracheal aspirate of a 71-year-old male patient in the General Hospital [GH] in Pula, Croatia. The patient was previously treated in University Hospital Centre in Rijeka with colistin in order to eradicate Acinetobacter baumannii isolate, susceptible only to colistin and tigecycline. Genes encoding ESBLs [blaTEM, blaSHV, blaCTX-M, blaPER-1] were screened by PCR. The strain was shown to possess blaCTX-M-15 and blaTEM-1 genes. To asses genes possibly involved in resistance to colistin the chromosomal enconding mgrB gene and the plasmid-mediated mcr-1 and mcr-2 genes were screened as described previously. Mcr-1 and mcr-2 genes were not detected and mgrB gene presented a wild-type sequence. PCR-based Replicon typing method [PBRT] conducted on an E. aerogenes isolate, showed that the strain carried an IncN plasmid. Adaptive mechanisms such as changes of the bacterial cell outer membrane that cause porin decrease or presence of an efflux pump, due to selection pressure exerted by the therapeutic administration of colistin, could be responsible for the development of colistin resistance in our strain, as recently reported in E. aerogenes from France. Due to effective infection control measures, the colistin-resistant strain did not spread to other patients or hospital wards. This is the first report of an ESBL-producing, colistin-resistant E. aerogenes in clinically relevant samples such as endotracheal aspirate and blood culture, showing the presence of this rare resistance profile among Gram-negative bacteria.

KW - Colistin

KW - Enterobacter aerogenes

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=85032031962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032031962&partnerID=8YFLogxK

U2 - 10.1080/1120009X.2017.1382121

DO - 10.1080/1120009X.2017.1382121

M3 - Article

AN - SCOPUS:85032031962

SP - 1

EP - 4

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

ER -